149 related articles for article (PubMed ID: 36509133)
21. Effect of brimonidine on retinal and choroidal neovascularization in a mouse model of retinopathy of prematurity and laser-treated rats.
Kusari J; Padillo E; Zhou SX; Bai Y; Wang J; Song Z; Zhu M; Le YZ; Gil DW
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5424-31. PubMed ID: 21482645
[TBL] [Abstract][Full Text] [Related]
22. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
[TBL] [Abstract][Full Text] [Related]
23. Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability.
Peters S; Cree IA; Alexander R; Turowski P; Ockrim Z; Patel J; Boyd SR; Joussen AM; Ziemssen F; Hykin PG; Moss SE
Cytokine; 2007 Nov; 40(2):144-50. PubMed ID: 17959386
[TBL] [Abstract][Full Text] [Related]
24. Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration.
Qiu F; Meng T; Chen Q; Zhou K; Shao Y; Matlock G; Ma X; Wu W; Du Y; Wang X; Deng G; Ma JX; Xu Q
Mol Pharm; 2019 May; 16(5):1958-1970. PubMed ID: 30912953
[TBL] [Abstract][Full Text] [Related]
25. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
Eyetech Study Group
Retina; 2002 Apr; 22(2):143-52. PubMed ID: 11927845
[TBL] [Abstract][Full Text] [Related]
26. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
27. Beneficial effects of the Src inhibitor, dasatinib, on breakdown of the blood-retinal barrier.
Kim SR; Suh W
Arch Pharm Res; 2017 Feb; 40(2):197-203. PubMed ID: 27988882
[TBL] [Abstract][Full Text] [Related]
28. PHD2 attenuates high-glucose-induced blood retinal barrier breakdown in human retinal microvascular endothelial cells by regulating the Hif-1α/VEGF pathway.
Li J; Lu X; Wei L; Ye D; Lin J; Tang X; Cui K; Yu S; Xu Y; Liang X
Inflamm Res; 2022 Jan; 71(1):69-79. PubMed ID: 34773469
[TBL] [Abstract][Full Text] [Related]
29. Sustained suppression of VEGF for treatment of retinal/choroidal vascular diseases.
Campochiaro PA; Akhlaq A
Prog Retin Eye Res; 2021 Jul; 83():100921. PubMed ID: 33248215
[TBL] [Abstract][Full Text] [Related]
30. Atrial natriuretic peptide reduces vascular leakage and choroidal neovascularization.
Lara-Castillo N; Zandi S; Nakao S; Ito Y; Noda K; She H; Ahmed M; Frimmel S; Ablonczy Z; Hafezi-Moghadam A
Am J Pathol; 2009 Dec; 175(6):2343-50. PubMed ID: 19910509
[TBL] [Abstract][Full Text] [Related]
31. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.
Vinores SA; Youssri AI; Luna JD; Chen YS; Bhargave S; Vinores MA; Schoenfeld CL; Peng B; Chan CC; LaRochelle W; Green WR; Campochiaro PA
Histol Histopathol; 1997 Jan; 12(1):99-109. PubMed ID: 9046048
[TBL] [Abstract][Full Text] [Related]
33. Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis.
Mei X; Zhou L; Zhang T; Lu B; Sheng Y; Ji L
Vascul Pharmacol; 2018 Feb; 101():29-37. PubMed ID: 29146180
[TBL] [Abstract][Full Text] [Related]
34. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization.
Takagi H; Koyama S; Seike H; Oh H; Otani A; Matsumura M; Honda Y
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):393-402. PubMed ID: 12506101
[TBL] [Abstract][Full Text] [Related]
35. The interaction between the renin-angiotensin system and vascular endothelial growth factor in the pathogenesis of retinal neovascularization in diabetes.
Wilkinson-Berka JL; Kelly DJ; Gilbert RE
J Vasc Res; 2001; 38(6):527-35. PubMed ID: 11740151
[TBL] [Abstract][Full Text] [Related]
36. [Impact of anti-VEGF therapy on the cellular microenvironment in retinal angiogenesis].
Nakao S
Nippon Ganka Gakkai Zasshi; 2014 Nov; 118(11):943-52. PubMed ID: 25543385
[TBL] [Abstract][Full Text] [Related]
37. Newly Identified Peptide, Peptide Lv, Promotes Pathological Angiogenesis.
Shi L; Zhao M; Abbey CA; Tsai SH; Xie W; Pham D; Chapman S; Bayless KJ; Hein TW; Rosa RH; Ko ML; Kuo L; Ko GY
J Am Heart Assoc; 2019 Nov; 8(22):e013673. PubMed ID: 31698979
[TBL] [Abstract][Full Text] [Related]
38. Nanoengineering of therapeutics for retinal vascular disease.
Gahlaut N; Suarez S; Uddin MI; Gordon AY; Evans SM; Jayagopal A
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):323-30. PubMed ID: 26022642
[TBL] [Abstract][Full Text] [Related]
39. EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown.
Ojima T; Takagi H; Suzuma K; Oh H; Suzuma I; Ohashi H; Watanabe D; Suganami E; Murakami T; Kurimoto M; Honda Y; Yoshimura N
Am J Pathol; 2006 Jan; 168(1):331-9. PubMed ID: 16400034
[TBL] [Abstract][Full Text] [Related]
40. Müller cell-derived VEGF is a significant contributor to retinal neovascularization.
Bai Y; Ma JX; Guo J; Wang J; Zhu M; Chen Y; Le YZ
J Pathol; 2009 Dec; 219(4):446-54. PubMed ID: 19768732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
